Anorectal

Manufacturer
Walgrrens | Product Quest
Effective date
2017-10-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:52:40

Label at a glance#

ProductAnorectal Walgreens
Active ingredientLidocaine
Label structure7 sections

Label contents#

Full prescribing information#

Active ingredient                               Purpose

OTC - ACTIVE INGREDIENT SECTION


Lidocaine 5%......................................Local anesthetic

INDICATIONS & USAGE SECTION

Uses For temporary relief of pain, soreness and burning.

WarningsFor external use only

WARNINGS SECTION

When using this product do not get into eyes.
Stop use and ask a doctor if • condition worsens or does
not improve within 7 days • do not exceed the
recommended daily dosage unless directed by a doctor
• in case of bleeding, consult a doctor promptly • do not put this product into the rectum by using fingers or any mechanical device or applicator

  • certan persons can develop allergic reactions to ingredients in this product. If the simptoms being treated does not subside or if redness, irritation, swelling, or other simproms develop or increase, discontinue use and consult a doctor

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical
help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions Apply externally to affected area up to 6 times daily. Gently dry by patting or blotting with tissue or a soft cloth before application of this product

OTHER SAFETY INFORMATION

Other information Store at 25° C (77° F);
excursions permitted to 15-30˚ C (59-86˚ F).

INACTIVE INGREDIENT SECTION

Inactive ingredients
Benzyl Alcohol, Carbomer 940, Cholesterol, Hydrogenated Lecithin, Isopropyl Myristate, Polysorbate 80, Propylene Glycol, Purified Water, Trolamine, Vitamin E Acetate.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1366789lidocaine 5 % Rectal CreamPSN1
1366789lidocaine 50 MG/ML Rectal CreamSCD1
1366789lidocaine 5 % Rectal CreamSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0363-1114-012020-01-31C16284748780-19d75b9d0-33d3-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0363-1114-01AnorectalWalgreens28.3 mL in 1 TUBECREAM28.31
0363-1114-01AnorectalWalgreens1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0363-1114ANORECTAL WALGREENS (LIDOCAINE) CREAM [WALGRRENS]1Legacy NDC, 2 package rows20171011_f72e9a3c-a194-4b71-961f-f811b22185e9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-11140363-1114-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
25cfb264-0ff0-49b8-881a-8c2a40e4134df72e9a3c-a194-4b71-961f-f811b22185e92017-10-10WarningsExact identifier
spl id: 25cfb264-0ff0-49b8-881a-8c2a40e4134d
spl set id: f72e9a3c-a194-4b71-961f-f811b22185e9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.